Literature DB >> 4007883

Plasma hydrazine concentrations in man after isoniazid and hydralazine administration.

I A Blair, R Mansilla Tinoco, M J Brodie, R A Clare, C T Dollery, J A Timbrell, I A Beever.   

Abstract

By using a specific sensitive stable-isotope dilution gas chromatography-mass spectrometry (GC-MS) assay, hydrazine was detected in the plasma of eight healthy male volunteer subjects taking isoniazid (300 mg daily) for 2 weeks. Accumulation of hydrazine occurred in slow-acetylator phenotypes. Hydrazine was also detected in the plasma of eight out of 14 hypertensive patients treated chronically with hydralazine (200 mg daily). However, the concentrations of hydrazine observed were much lower than in the isoniazid study and were close to the limit of detection. As hydrazine is hepatotoxic, mutagenic and carcinogenic in animals, its presence in human plasma has important toxicological implications.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007883     DOI: 10.1177/096032718500400210

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  17 in total

1.  The Isoniazid Metabolites Hydrazine and Pyridoxal Isonicotinoyl Hydrazone Modulate Heme Biosynthesis.

Authors:  Christopher Trent Brewer; Lei Yang; Anne Edwards; Yan Lu; Jonathan Low; Jing Wu; Richard E Lee; Taosheng Chen
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

2.  A biochemical and NMR spectroscopic study of hydrazine in the isolated rat hepatocyte.

Authors:  S Ghatineh; W Morgan; N E Preece; J A Timbrell
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

3.  Liver and pancreatic injury induced by antituberculous therapy.

Authors:  M Markov; K Patel; A Raeesy; A Bant; D H Van Thiel; A Nadir
Journal:  Dig Dis Sci       Date:  2007-02-15       Impact factor: 3.199

4.  Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazid.

Authors:  E Peretti; G Karlaganis; B H Lauterburg
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Lack of liver injury in Wistar rats treated with the combination of isoniazid and rifampicin.

Authors:  Imir G Metushi; Jack Uetrecht
Journal:  Mol Cell Biochem       Date:  2013-10-23       Impact factor: 3.396

6.  Quantification of Hydrazine in Human Urine by HPLC-MS-MS.

Authors:  Samantha L Isenberg; Melissa D Carter; Brian S Crow; Leigh Ann Graham; Darryl Johnson; Nick Beninato; Kandace Steele; Jerry D Thomas; Rudolph C Johnson
Journal:  J Anal Toxicol       Date:  2016-03-13       Impact factor: 3.367

7.  Proton NMR spectroscopic studies on the metabolism and biochemical effects of hydrazine in vivo.

Authors:  S M Sanins; J A Timbrell; C Elcombe; J K Nicholson
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

8.  Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo.

Authors:  A M Jenner; J A Timbrell
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  Factors in hydrazine formation from isoniazid by paediatric and adult tuberculosis patients.

Authors:  W L Gent; H I Seifart; D P Parkin; P R Donald; J H Lamprecht
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  Hydralazine use in relation to cancers of the lung, colon, and rectum.

Authors:  D W Kaufman; J P Kelly; L Rosenberg; P D Stolley; M E Warshauer; S Shapiro
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.